In the BioHarmony Drug Report Database

"Preview" Icon

Trimipramine

Surmontil (trimipramine) is a small molecule pharmaceutical. Trimipramine was first approved as Surmontil on 1982-01-01. It is used to treat depressive disorder and psychotic affective disorders in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter, sodium-dependent serotonin transporter, and sodium-dependent noradrenaline transporter. In addition, it is known to target G protein-activated inward rectifier potassium channel 2, muscarinic acetylcholine receptor M2, potassium voltage-gated channel subfamily H member 1, and G protein-activated inward rectifier potassium channel 4.

 

Trade Name

 

Surmontil
 

Common Name

 

trimipramine
 

ChEMBL ID

 

CHEMBL644
 

Indication

 

depressive disorder, psychotic affective disorders
 

Drug Class

 

Antidepressants (imipramine type)

Image (chem structure or protein)

Trimipramine structure rendering